NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

iStock photo of girl eating burger
Want to know what people think of Raleigh? Or Charlotte? Where to buy your next McMeal? Then check out Numbeo. It's saying Raleigh and Charlotte are among the best metros in the world for quality of life.
Sagent Pharmaceuticals North Raleigh factory
A north Raleigh drug-manufacturing site purchased in 2014 by Denmark-based Xellia Pharmaceuticals has been sold again -- this time to Sagent Pharmaceuticals of Schaumburg, Illinois.
Precision BioSciences loto
Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.
Dignify Therapeutics logo
Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a future Phase 1 clinical study.
Investor panel at 2019 CED Life Science Conference
A panel of venture investment fund managers offered their insights into raising venture capital in the life sciences Wednesday during the 2019 CED Life Science Conference at the Raleigh Convention Center.
John Carreyrou photo
For any bioscience entrepreneurs in North Carolina who may be tempted to exaggerate claims about their products and technologies, investigative journalist John Carreyrou has some advice: do so at your own peril.
Several North Carolina Biotechnology Center portfolio companies are among the array of life science startups presenting their wares at the 2019 CED Life Science Conference today and Wednesday at the Raleigh Convention Center, including some that presented a year ago.
Shutterstock photo of street crowd
Population screening can use genetic information to identify seemingly healthy people who harbor a high risk of a hereditary disease, well before they become ill.
Climate change iStock image
It’s no secret that agriculture is highly dependent on climate, and the effects of global warming on crops are a complex problem. Those recognitions were jumping-off points for discussions from executives of two of North Carolina’s leading global agricultural biotechnology companies during NCBiotech's Ag Tech Professional Forum.

With uncertain weather forecast, the NCBiotech RTP office is opening at noon on Wednesday February 20.

Many of us will be checking in from home. Please stay safe out there.

LabCorp logo
Burlington-based LabCorp is offering a new assay to help doctors monitor drug responses in patients taking Certolizumab, a biologic therapy for certain inflammatory diseases such as rheumatoid arthritis and Crohn’s disease.
AveXis logo
North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.
Glenmark logo
Glenmark Pharmaceuticals, the largest pharmaceutical manufacturer in the Greater Charlotte region, is bringing a big “Help Wanted” message to the North Carolina Biotechnology Center’s monthly Jobs Network event, in search of production employees to help meet its fast-growing demand.
Syneos logo
Syneos Health is joining the worldwide annual observance of Rare Disease Day, Thursday, February 28, by hosting a free public in-depth Rare Disease Day Symposium, from 11:30 a.m. to 3 p.m., at its new global headquarters in Morrisville.
TARGET logo
Durham-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has launched a new observational study of several inflammatory skin conditions, initially focusing on eczema.